Podcasts about aum cardiovascular

Marie Johnson, CEO and founder of AUM Cardiovascular, lost her husband, Rob, to a heart attack. The tragedy led her to develop CADence, a handheld device that she believes will save lives by identifying telltale signs of cardiovascular disease.

Marie Johnson, CEO and founder of AUM Cardiovascular, lost her husband, Rob, to a heart attack. The tragedy led her to develop CADence, a handheld device that she believes will save lives by identifying telltale signs of cardiovascular disease.

It’s called the widow maker for a reason as Dr. Marie Johnson experienced when her 41-year old, seemingly healthy husband died suddenly from Coronary Artery Disease or CAD — the number one killer among both men and women. And predicting a heart attack using standard risk factors is generally insufficient. Learn how Dr. Johnson went from tragedy to innovation to launching AUM Cardiovascular with CADense, a non-invasive acoustic and ECG device designed to help physicians detect physiological and pathological heart murmurs.

More than a decade ago, AUM Cardiovascular founder Dr. Marie Johnson was a doctoral student when tragedy struck her and her family. Her husband, Rob, passed away suddenly at the age of 41. He had blockages in his coronary arteries including a ruptured plaque in the left anterior descending artery supplying a large part of...[read more]Related StoriesWhy Intersect ENT is an Example of Hope for the Medtech IndustryAre Medical Device Models the Key to Building a Lean Medtech Startup?Substantial and Sustainable – 2 Words That Medtech Companies Should Get Used To

Marie Johnson turned tragedy into a mission. In 2002, the CEO of Aum Cardiovascular lost her husband to a sudden heart attack, despite the fact that he was, by all accounts, a perfectly healthy man. Fast forward 13 years and her company has commercialized a non-invasive test designed to quickly detect significant coronary stenosis called the CADence. Johnson hopes the pre FDA-approved device, which is on the market in Germany, will eliminate needless death due to coronary artery disease. In this interview, recorded live at our DeviceTalks Minnesota event, touches on Johnson's incredible story.